Clinical Trial Details
EORTC-62932
Back to Clinical Trials Database
Phase II study of daily oral vepeside (etoposide VP16-213) as second line treatment in advanced soft tissue sarcomas
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 07-Dec-1993 Date Step1 close: 20-Jun-1994 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 25 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |